Deciphering molecular stress response is highly relevant to studies of microbes such as 12 Mycobacterium tuberculosis (MTB), the causative pathogen of tuberculosis (TB) which 13 sickens 10 million people and kills 1.8 million each year 1 . Prolonged therapy and 14 unfavorable outcomes arise partially because MTB has evolved stress responses to 15 achieve tolerance, wherein MTB persists in otherwise inhibitory drug concentrations by 16 means independent of heritable resistance mutations [2][3][4] . Understanding these 17 adaptations and how they are regulated can reveal new biology, including unexplored 18 drug targets and treatment-enhancing strategies. Here, we present a novel network-19 based genetic screening approach: the Transcriptional Regulator Induced Phenotype 20 (TRIP) screen, which we used to identify previously uncharacterized MTB network 21 2 adaptations to the first-line drug isoniazid (INH). We found regulators that alter INH 22 susceptibility when induced, several of which could not be identified by standard gene 23 disruption approaches. We then focused on a specific regulator, mce3R, which 24 potentiated INH when induced. We compared mce3R-regulated genes with the baseline 25 INH transcriptional response and implicated the gene Rv1469 as a putative INH 26 effector. Phenotyping a disruption mutant strain then demonstrated a previously 27 unknown role for Rv1469 in INH susceptibility. Integrating TRIP screening with network 28 data can uncover sophisticated molecular response programs. 29 30
. Schematic of TRIP screen.
To address these limitations, we developed a strategy that quantifies growth associated 42 with individually inducing each MTB transcription factor (TF). This Transcriptional interactions triggered by each TF [13] [14] [15] . 57 Here, we pool the TFI strain library for simultaneous measurement of strain growth 58 (Figure 1) . The pool is exposed to a stress condition either with or without TF induction. 59 The proportion of each TFI strain in the pool is quantified by next-generation 60 sequencing of a DNA segment unique to each strain (see Methods for details).
61
To validate differences in relative abundance detected by TRIP, we compared the TRIP 87 output with the growth of each individual TFI strain over a one-week time course with 88 and without TF induction. Of the 22 TFI strains with strong growth defects in the TRIP 89 assay, 20 also had strong growth defects when cultured individually. This validation 90 indicates that 1) phenotypes detected by TRIP reflect growth observed in monoculture, 91 and 2) significant growth defect upon TF induction is an uncommon and highly TF-92 specific effect.
93
Once baseline MTB network phenotypes were established, we applied TRIP to study 94 response to INH. We exposed TFI pools to a dose of INH where the bulk population 95 grew suboptimally (19% of untreated, see Figure S1 ), enabling us to identify TFIs with 96 reduced and improved viability compared to the population average in a single 97 experiment. Figure 2D shows abundance of each TFI strain exposed to drug in the 98 induced condition relative to uninduced. TFI strains with a growth phenotype specific to 99 INH partition into three groups: A) TFIs that convey growth advantage in INH but no 100 change in when untreated (7 strains, purple box); B) TFIs that convey growth defect in 101 INH but no change when untreated (4 strains, blue box); and C) TFIs that convey 102 growth defect in both INH and untreated conditions (9 strains; light blue box). The genes 103 whose promoters are bound by TFs in group A are enriched for transporter functions 104 in the presence of INH is known to restore nearly uninhibited growth 14, 17, 19 . 119 We next sought to investigate regulons that represented potential novel therapeutic To validate its hypersusceptibility, we tested viability of the mce3R induction strain in 125 monoculture under INH treatment. First, we exposed the strain to INH, with and without 126 induction of mce3R (Figure 2E) . We confirmed induction of mce3R by qPCR ( Figure   127 S2), and observed a significant, 4-fold additional growth defect by 7 days of INH 128 exposure, and a 21-fold additional defect by day 14. In addition, we also assayed MTB 129 ATP levels (BacTiter Glo, Promega, Madison, WI) after 7 days of treatment with varying 130 doses of INH ( Figure 2F ). We found that at every non-zero INH concentration we 131 tested, induction of mce3R resulted in significantly lower metabolic viability, 132 demonstrating that mce3R-mediated hypersusceptibility is independent of drug 133 concentration.
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Hypersusceptibility could stem from some TFI-mediated countering of the MTB 135 adaptation to INH. To investigate this hypothesis, we compared the mce3R induction 136 regulon determined in our basal transcriptional network with the genes differentially 137 expressed when H37Rv is exposed to INH 14,23,24 . Rv1469 is one of two genes 138 repressed by mce3R (Figure 3A , see Figure S3 for full set), and Rv1469 is normally 139 upregulated in response to INH in broth culture and under macrophage infection 140 conditions 23, 24 . After ruling out the other gene (see Table S4 and . Both strains were exposed to 3.6µM INH (black) vs. no drug (white). Error bars indicate standard deviation from three replicates. The * indicates significant difference between the mutant and wildtype strains.
Rv1469 encodes a membrane protein 25 annotated as the MTB homolog of CtpD, a 153 member of the metal cation-transporting P1B4-ATPase subgroup, which is essential for 154 MTB survival in the host 6, 26, 27 . CtpD is a high-affinity Fe 2+ exporter needed for 155 overcoming redox stress and adapting to the host environment 26, 28 . Given that KatG- TRIP samples network states that are distinct from those resulting from TF disruption.
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For example, mce3R was previously reported to regulate the mce3 operon genes based 175 on studies of a deletion mutant 20,21 . However, the transcriptional impact of inducing 176 mce3R does not include the mce3 operon (see tab 3 of Table S2 for full regulon, based 177 on data from 14 ), suggesting that mce3R participates in complex regulatory circuits. 
